On24 ONTF

August 19, 2021 - 11:31am EST by

member

						2021	2022
Price:		19.80		EPS		0	0
Shares Out. (in M):		54		P/E		0	0
Market Cap (in $M):		1,080		P/FCF		0	0
Net Debt (in $M):		-396		EBIT		1	3
TEV (in $M):		683		TEV/EBIT		higher	high

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

show sort by

You are not eligible to view 15 messages. To gain access to more recent message posts signup free for membership.

18	member 4/03/19 9:29PM Re: Re: Still involved? 17
Are you following cvs as well? I’m on the fence there - I think Aetna will grow, retail will decline, and Caremark I’m not sure...If that’s stable the stock’s prob too cheap - but not view available tags
11	member 6/18/17 8:56AM Amzn
Any thoughts on CNBC piece last month on amzn looking more seriously on developing or buying a PBM and pharmaceutical platform, beginning with internally developing their own PBM? im less concerned by the WFM acquisition, as... login to read the rest 1 view available tags
7	member 2/02/17 12:14PM Re: Re: Re: Re: Re: Re: Why WBA over CVS? 6
Thanks - That report is interesting, appears to be the lobbying position of most of retail pharma excluding CVS -there are 4 bil RX dispensed at retail annually in US, so the $2 - $7 DIR... login to read the rest view available tags
5	member 2/02/17 11:16AM Re: Re: Re: Re: Why WBA over CVS? 4
"I'm not a PBM uber-bear, and think that they absolutely provide value. At the same time, I do think that they smartly use GAAP accounting to make their business look less profitable than it really... login to read the rest view available tags

load more messages